8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15 (d) of the Securities and Exchange Act of 1934

Date of report (Date of earliest event reported):

April 26, 2007

EASTMAN CHEMICAL COMPANY

(Exact Name of Registrant as Specified in Its Charter)

Delaware	1-12626	62-1539359
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

200 South Wilcox Drive, Kingsport, TN	37660
(Address of Principal Executive Offices)	(Zip Code)

(423) 229-2000

(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

EASTMAN CHEMICAL COMPANY - EMN      April 26, 2007   

Item 2.02 Results of Operations and Financial Condition

On April 26, 2007, the registrant publicly released its financial results for first-quarter 2007. The full text of the release is furnished as Exhibit 99.01 to this Form 8-K, and is incorporated herein by reference. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

This Form 8-K includes the following non-GAAP financial measures:

·   Eastman Chemical Company and segment sales excluding contract ethylene sales under a transition agreement related to the previous divestiture of the polyethylene product lines;

·   Eastman Chemical Company Operating Earnings, Earnings Before Tax, Net Earnings and Earnings Per Diluted Share excluding accelerated depreciation costs and asset impairments and restructuring charges; and

·   Segment Operating Earnings excluding accelerated depreciation costs and asset impairments and restructuring charges.

Eastman's management believes that sales from contract ethylene sales under the transition agreement related to the previous divestiture of the polyethylene product lines do not reflect the continuing and expected future business of the Performance Chemicals and Intermediates ("PCI") segment.  In addition, management believes that corporate and segment earnings should be considered both with and without accelerated depreciation costs and asset impairments and restructuring charges for evaluation and analysis of ongoing business results. However, management believes that these items are indicative of results of continuous efforts to reduce costs and of actions to improve the profitability of the company. Management believes that investors can better evaluate and analyze historical and future business trends if they also consider the reported corporate and segment results, respectively, without the identified items. Management utilizes corporate and segment results including and excluding the identified items in the measures it uses to evaluate business performance and in determining certain performance-based compensation. These measures, excluding the identified items, are not recognized in accordance with GAAP and should not be viewed as alternatives to the GAAP measures of performance.  Tables 3, 4 and 6 in the accompanying first quarter 2007 financial tables reconcile:

o   Operating Earnings, Earnings Before Tax, Net Earnings and Net Earnings Per Diluted Share on a GAAP basis, as reflected in Eastman's Consolidated Statements of Earnings, to Operating Earnings, Earnings Before Tax, Net Earnings, and Net Earnings Per Diluted Share excluding accelerated depreciation costs and asset impairments and restructuring charges; and

o   Sales Revenue on a GAAP basis, as reflected in Eastman's Consolidated Statements of Earnings, to Sales Revenue excluding sales revenue resulting from contract ethylene sales under a transition agreement related to the previous divestiture of the polyethylene product lines.

In addition, the Company has chosen separately to present Sales, Operating Earnings (Loss), Accelerated Depreciation Costs, and Asset Impairments and Restructuring Charges attributable to recently divested product lines. Tables 4 and 5 in the accompanying first quarter 2007 financial tables provide this information on a GAAP basis.

EASTMAN CHEMICAL COMPANY - EMN  April 26, 2007 

Item 9.01 Financial Statements and Exhibits:

(d) Exhibits

The following exhibit is furnished pursuant to Item 9.01:

99.01 Public release by the registrant on April 26, 2007 of first-quarter 2007 financial results.

EASTMAN CHEMICAL COMPANY - EMN    April 26, 2007   

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

Eastman Chemical Company 

By: /s/ Curtis E. Espeland

 Curtis E. Espeland

 Vice President and Chief Accounting Officer

Date:  April 26, 2007

EX-99.01

For Release April 26, 2007	Contacts:
5:00 p.m. EDT	Media: Fletcher Dean
	423-229-5264 / fdean@eastman.com
	Investors:Greg Riddle
	212-835-1620 / griddle@eastman.com

Eastman Announces First-Quarter 2007 Financial Results

KINGSPORT, Tenn., April 26, 2007 - Eastman Chemical Company (NYSE:EMN) today announced earnings of $0.91 per diluted share for first quarter 2007 versus earnings of $1.27 per diluted share for first quarter 2006. Excluding the items described in the following paragraph, first-quarter 2007 earnings were $1.19 per diluted share, while first-quarter 2006 earnings were $1.36 per diluted share. For reconciliations to reported company and segment earnings, see Tables 3, 5 and 6 in the accompanying first-quarter 2007 financial tables.

Included in the results for first quarter 2007 were accelerated depreciation costs of $14 million resulting from continuing restructuring actions at the company's Longview, Texas, and Columbia, S.C., facilities and asset impairments and restructuring charges of $21 million primarily related to the recently announced divestiture of the company's San Roque, Spain, PET facility. First quarter 2006 results included asset impairments and restructuring charges of $7 million.

"Operating earnings for the company remained strong year over year with the exception of our PET business," said Brian Ferguson, chairman and CEO. "We continue to make good progress offsetting high and volatile raw material and energy costs, and we remain confident the actions being taken with our PET business will substantially improve results in the Performance Polymers segment."

(In millions, except per share amounts)	1Q2007	1Q2006
Sales revenue	$1,795	$1,803
Earnings per diluted share	$0.91	$1.27
Earnings per diluted share excluding accelerated depreciation costs and asset impairments and restructuring charges*	$1.19	$1.36
Net cash provided by operating activities	$(66)	$37

* For reconciliation to reported company and segment earnings, see Table 3, 5 and 6 in the accompanying first-quarter 2007 financial tables.

Sales revenue for first quarter 2007 was $1.8 billion, flat compared with first quarter 2006. First quarter 2007 results included contract ethylene sales resulting from the divestiture of the polyethylene business while first quarter 2006 results included sales from divested product lines. Excluding the contract ethylene sales and sales from the divested product lines, sales revenue increased by 10 percent due to higher sales volume of 5 percent and higher selling prices. For reconciliations to reported company and segment sales revenue, see Tables 4 and 5 in the accompanying first-quarter 2007 financial tables.

Operating earnings in first quarter 2007 were $135 million compared with operating earnings of $184 million in first quarter 2006. Excluding accelerated depreciation from first quarter 2007 and asset impairments and restructuring charges from both first quarter 2007 and first quarter 2006, operating earnings were $170 million in first quarter 2007 compared with $191 million in first quarter 2006. The decline was due primarily to lower operating results in the Performance Polymers segment. The company's first-quarter 2007 raw material and energy costs increased by approximately $50 million compared with first quarter 2006.

Segment Results 1Q 2007 versus 1Q 2006

Coatings, Adhesives, Specialty Polymers and Inks - Sales revenue declined by 1 percent as higher selling prices were more than offset by lower sales volume, particularly in adhesives product lines. The lower sales volume was attributed to the divestiture of the company's Epolene product lines in fourth quarter 2006 and reduced demand in certain adhesives products. Excluding asset impairments and restructuring charges of $7 million for first quarter 2006, operating earnings for the segment increased to $65 million in first quarter 2007 from $62 million in first quarter 2006 due to higher selling prices more than offsetting higher raw material and energy costs and lower sales volume.

Fibers - Sales revenue increased by 2 percent as higher selling prices were offset by lower sales volume. The higher selling prices were due to efforts to offset higher raw material and energy costs, particularly for wood pulp and methanol. The lower sales volume was attributed to customer buying patterns for both acetyl chemicals and acetate yarn product lines. Operating earnings declined to $59 million in first quarter 2007 compared with $66 million in first quarter 2006 primarily due to lower sales volume and higher raw material and energy costs.

Performance Chemicals and Intermediates - Sales revenue increased by 27 percent as higher sales volume more than offset lower selling prices, with both sales volume and selling prices significantly impacted by contract ethylene sales resulting from the divestiture of the polyethylene business. Excluding the contract ethylene sales and divested product lines associated with the Arkansas manufacturing facility, PCI's sales revenue increased 18 percent due to an increase in sales volume of 14 percent and higher selling prices. The higher sales volume and increased selling prices were attributed to strong demand, particularly for olefin-based derivative products in Asia Pacific and the United States. Operating earnings, excluding asset impairments and restructuring charges and accelerated depreciation, increased to $61 million in first quarter 2007 compared with $41 million in first quarter 2006 due to higher selling prices and increased sales volume, with contract ethylene sales having minimal impact.

Performance Polymers - Sales revenue declined by 22 percent due to the divestiture of the polyethylene business during the fourth quarter 2006. Sales revenue for the continuing PET polymers product lines increased 9 percent due to higher sales volume primarily in Latin America attributed to continued strong demand in the region. First quarter 2007 results included asset impairments and restructuring costs of $21 million and accelerated depreciation of $7 million. Excluding those items, operating results for continuing PET product lines declined to a loss of $23 million in first quarter 2007 compared to a loss of $6 million in first quarter 2006. The decline, primarily in North America, was due to lower selling prices and higher and continued volatile raw material and energy costs which resulted in compressed gross margins. The results were impacted by costs associated with the new PET facility based on IntegRex technology becoming fully operational and the timing of the commercial launch of ParaStar PET which is produced from the IntegRex facility.

Specialty Plastics - Sales revenue increased by 13 percent due primarily to increased sales volume and higher selling prices. The increased sales volume was due to continued market development efforts, particularly in copolyester product lines. Operating earnings were $18 million in both periods as increased sales volume and higher selling prices were mostly offset by higher raw material and energy costs, particularly for paraxylene.

Cash Flow

Eastman used $66 million in cash from operating activities during first quarter 2007 which included a $100 million contribution to its U.S. defined benefit pension plan. The company does not plan to make additional contributions to the U.S. pension plan in 2007. Priorities for use of available cash continue to be to pay the dividend, fund targeted growth initiatives, and to repurchase shares under the authorized share repurchase plan. During the first quarter, share repurchases totaled $33 million.

Outlook

Commenting on the outlook for second quarter 2007, Ferguson said, "During the second quarter, we expect continued solid results in all of our segments, with the exception of Performance Polymers, despite continued high and volatile raw material and energy costs for the company. For the Performance Polymers segment, we anticipate improved results sequentially as the positive impacts of the company's IntegRex technology PET facility are partially offset by continued challenging business conditions. As a result, we expect second-quarter 2007 earnings per share excluding items related to ongoing strategic decisions to be between the middle to the low end of the First Call range of analyst estimates. The current range of analyst estimates on First Call for second quarter 2007 is $1.14 to $1.64, with a mean estimate of $1.33."

Eastman will host a conference call with industry analysts on April 27 at 8:00 a.m. EDT. To listen to the live webcast of the conference call, go to www.eastman.com, Investors, Event Information, Audio Archives. To listen via telephone, the dial-in number is (719) 457-2621, passcode number 7473205. A telephone replay will be available continuously from 11:00 a.m. EDT, April 27, to 12:00 midnight EDT, May 4, at 888-203-1112, passcode number 7473205.

Eastman manufactures and markets chemicals, fibers and plastics worldwide. It provides key differentiated coatings, adhesives and specialty plastics products; is the world’s largest producer of PET polymers for packaging; and is a major supplier of cellulose acetate fibers. As a Responsible Care® company, Eastman is committed to achieving the highest standards of health, safety, environmental and security performance. Founded in 1920 and headquartered in Kingsport, Tenn., Eastman is a FORTUNE 500 company with 2006 sales of $7.5 billion and approximately 11,000 employees. For more information about Eastman and its products, visit www.eastman.com.

###

Forward Looking Statements:

Forward Looking Statements: This news release includes forward-looking statements concerning current expectations for future economic and business conditions; raw material and energy costs; operation of new manufacturing facilities; costs of and improved financial performance from strategic restructuring decisions and actions; and earnings of the company and its segments for second quarter 2007.  Such expectations are based upon certain preliminary information, internal estimates, and management assumptions, expectations and plans, and are subject to a number of risks and uncertainties inherent in projecting future conditions, events, and results. Actual results could differ materially from expectations expressed in the forward-looking statements if one or more of the underlying assumptions or expectations prove to be inaccurate or are unrealized. Important factors that could cause actual results to differ materially from such expectations are and will be detailed in the company’s filings with the Securities and Exchange Commission, including the Form 10-K filed for full-year 2006 and the Form 10-Q to be filed for first quarter 2007, available on the Eastman web site at www.eastman.com in the Investors, SEC filings section.

EASTMAN CHEMICAL COMPANY - EMN	April 26, 2007
	5:00 PM EDT

FINANCIAL INFORMATION

April 26, 2007

For use in the Eastman Chemical Company Conference Call

at 8:00 AM (EDT), April 27, 2007.

Table of Contents

Item		Page
TABLE 1	Statements of Earnings	1
TABLE 2A	Other Sales Information	2
TABLE 2B	Sales Revenue Change	2
TABLE 2C	Sales by Region	3
TABLE 2D	Percentage Growth in Sales Volume by Region	3
TABLE 3	Operating Earnings (Loss), Accelerated Depreciation, Asset Impairments and Restructuring Charges and Other Operating (Income) Charges	4
TABLE 4	Eastman Chemical Company Detail of Sales Revenue	5
TABLE 5	Performance Polymers Segment Detail of Sales Revenue, Operating Earnings, Accelerated Depreciation, Asset Impairments and Restructuring Charges and Other Operating (Income) Charges	6
TABLE 6	Operating Earnings, Net Earnings, and Earnings Per Share Reconciliation	8
TABLE 7	Statements of Cash Flows	9
TABLE 8	Selected Balance Sheet Items	10

EASTMAN CHEMICAL COMPANY - EMN	April 26, 2007
	5:00 PM EDT
	Page 1

TABLE 1 - STATEMENTS OF EARNINGS

		First Quarter
(Dollars in millions, except per share amounts)		2007		2006
Sales	$	1,795	$	1,803
Cost of sales		1,502		1,472
Gross profit		293		331
Selling, general and administrative expenses		101		98
Research and development expenses		36		42
Asset impairments and restructuring charges, net		21		7
Operating earnings		135		184
Interest expense, net		18		20
Other (income) charges, net		(3)		(1)
Earnings before income taxes		120		165
Provision for income taxes		43		60
Net earnings	$	77	$	105
Earnings per share
Basic	$	0.92	$	1.28
Diluted	$	0.91	$	1.27
Shares (in millions) outstanding at end of period		84.1		81.8
Shares (in millions) used for earnings per share calculation
Basic		83.9		81.5
Diluted		85.0		82.4

EASTMAN CHEMICAL COMPANY - EMN	April 26, 2007
	5:00 PM EDT
	Page 2

TABLE 2A - OTHER SALES INFORMATION

		First Quarter (1)
(Dollars in millions)		2007		2006
Sales by Segment
Coatings, Adhesives, Specialty Polymers, and Inks	$	345	$	349
Fibers		234		230
Performance Chemicals and Intermediates		498		392
Performance Polymers		506		645
Specialty Plastics		212		187
Total Sales by Segment		1,795		1,803
Other		--		--
Total Eastman Chemical Company	$	1,795	$	1,803

⁽¹⁾Amounts for sales have been adjusted to retrospectively apply changes for transfer of certain product lines between PCI and Performance Polymers.

TABLE 2B - SALES REVENUE CHANGE

	First Quarter 2007 Compared to First Quarter 2006
		Change in Sales Revenue Due To
	Revenue % Change	Volume Effect	Price Effect	Product Mix Effect	Exchange Rate Effect
Coatings, Adhesives, Specialty Polymers, and Inks (1)	(1) %	(8) %	5 %	-- %	2 %
Fibers	2 %	(4) %	4 %	2 %	-- %
Performance Chemicals and Intermediates (1) (2)	27 %	34 %	(14) %	6 %	1 %
Performance Polymers (1)	(22) %	(24) %	-- %	-- %	2 %
Specialty Plastics	13 %	8 %	3 %	-- %	2 %
Total Eastman Chemical Company	-- %	(2) %	(1) %	1 %	2 %

⁽¹⁾ Includes the sales revenue from divestitures of the Company's Batesville, Arkansas manufacturing facility and related assets in the Performance Chemicals and Intermediates ("PCI") segment and its polyethylene ("PE") and Epolene polymer businesses and related assets of the Performance Polymers and Coatings, Adhesives, Specialty Polymers, and Inks ("CASPI") segments

⁽²⁾ Includes sales revenue from the contract ethylene sales resulting from the divestiture of the PE business. Refer to Table 4 for more information.

EASTMAN CHEMICAL COMPANY - EMN	April 26, 2007
	5:00 PM EDT
	Page 3

TABLE 2C - SALES BY REGION

		First Quarter
(Dollars in millions)		2007		2006
Sales by Region
United States and Canada (1)	$	967	$	1,073
Europe, Middle East, and Africa		373		325
Asia Pacific		253		211
Latin America (1)		202		194
	$	1,795	$	1,803

⁽¹⁾ Sales for first quarter 2006 include sales revenue from divested product lines

TABLE 2D - PERCENTAGE GROWTH IN SALES VOLUME BY REGION

	First Quarter, 2007 Compared to First Quarter, 2006
Regional sales volume growth
United States and Canada	(2) %
Europe, Middle East, and Africa	4 %
Asia Pacific	12 %
Latin America	5 %

EASTMAN CHEMICAL COMPANY - EMN	April 26, 2007
	5:00 PM EDT
	Page 4

TABLE 3 - OPERATING EARNINGS (LOSS), ACCELERATED DEPRECIATION, AND ASSET IMPAIRMENTS AND RESTRUCTURING CHARGES

		First Quarter
(Dollars in millions)		2007		2006
Operating Earnings by Segment and Certain Items
Coatings, Adhesives, Specialty Polymers, and Inks
Operating earnings	$	65	$	55
Asset impairments and restructuring charges		--		7
Operating earnings excluding certain items		65		62
Fibers
Operating earnings		59		66
Performance Chemicals and Intermediates
Operating earnings		54		41
Accelerated depreciation included in cost of goods sold		7		--
Operating earnings excluding certain items		61		41
Performance Polymers
Operating earnings (loss)		(51)		17
Accelerated depreciation included in cost of goods sold		7		--
Asset impairments and restructuring charges		21		--
Operating earnings (loss) excluding certain items		(23)		17
Specialty Plastics
Operating earnings		18		18
Total Operating Earnings by Segment and Certain Items
Total operating earnings		145		197
Total accelerated depreciation included in cost of goods sold		14		--
Total asset impairments and restructuring charges		21		7
Total operating earnings excluding certain items		180		204
Other
Operating loss		(10)		(13)
Total Eastman Chemical Company
Total operating earnings	$	135	$	184
Total accelerated depreciation included in cost of goods sold		14		--
Total asset impairments and restructuring charges		21		7
Total operating earnings excluding certain items		170		191

EASTMAN CHEMICAL COMPANY - EMN	April 26, 2007
	5:00 PM EDT
	Page 5

TABLE 4 - EASTMAN CHEMICAL COMPANY DETAIL OF SALES REVENUE

		First Quarter	Second Quarter	Third Quarter	Fourth Quarter	Twelve Months
(Dollars in millions)		2007	2007	2007	2007	2007
Sales Revenue	$	1,795
Less: contract ethylene sales (1)		70
Sales revenue excluding contract ethylene sales	$	1,725

		First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Twelve Months
(Dollars in millions)		2006		2006		2006		2006		2006
Sales Revenue	$	1,803	$	1,929	$	1,966	$	1,752	$	7,450
Less: divested product lines
Coatings, Adhesives, Specialty Polymers and Inks (2)		18		17		18		12		65
Performance Chemicals and Intermediates (3)		30		29		38		14		111
Performance Polymers (2)		180		168		169		118		635
Sales revenue - continuing product lines	$	1,575	$	1,715	$	1,741	$	1,608	$	6,639

⁽¹⁾ Contract ethylene sales under the transition supply agreement related to the divestiture of the polyethylene businesses

⁽²⁾ Polyethylene and Epolene polymer businesses and related assets of the Performance Polymers and Coatings, Adhesives, Specialty Polymers, and Inks ("CASPI") segments located at the Longview, Texas site and the Company's ethylene pipeline were sold in fourth quarter 2006.

⁽³⁾ The Company's Batesville, Arkansas manufacturing facility and related assets and the specialty organic chemicals product lines in the Performance Chemicals and Intermediates ("PCI") segment were sold in fourth quarter 2006.

EASTMAN CHEMICAL COMPANY - EMN	April 26, 2007
	5:00 PM EDT
	Page 6

TABLE 5 - PERFORMANCE POLYMERS SEGMENT DETAIL OF SALES REVENUE, OPERATING EARNINGS (LOSS), ACCELERATED DEPRECIATION, ASSET IMPAIRMENTS AND RESTRUCTURING CHARGES AND OTHER OPERATING (INCOME) CHARGES

		First Quarter	Second Quarter	Third Quarter	Fourth Quarter	Twelve Months
(Dollars in millions)		2007	2007	2007	2007	2007
Sales Revenue
Performance Polymers divested product lines	$	--
Continuing product lines		506
Total sales revenue	$	506
Operating loss
Performance Polymers divested product lines (1)	$	--
Continuing product lines		(51)
Total operating earnings	$	(51)
Accelerated depreciation included in cost of goods sold
Performance Polymers divested product lines	$	--
Continuing product lines		7
Total accelerated depreciation	$	7
Asset impairments and restructuring charges, net
Performance Polymers divested product lines	$	--
Continuing product lines		21
Total asset impairments and restructuring charges, net	$	21

EASTMAN CHEMICAL COMPANY - EMN	April 26, 2007
	5:00 PM EDT
	Page 7

		First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Twelve Months
(Dollars in millions)		2006		2006		2006		2006		2006
Sales Revenue
Performance Polymers divested product lines	$	180	$	168	$	169	$	118	$	635
Continuing product lines		465		528		558		456		2,007
Total sales revenue	$	645	$	696	$	727	$	574	$	2,642
Operating earnings (loss)
Performance Polymers divested product lines (1)	$	23	$	15	$	15	$	83	$	136
Continuing product lines		(6)		(1)		5		(80)		(82)
Total operating earnings	$	17	$	14	$	20	$	3	$	54
Accelerated depreciation included in cost of goods sold
Performance Polymers divested product lines	$	--	$	--	$	--	$	--	$	--
Continuing product lines		--		--		--		7		7
Total accelerated depreciation	$	--	$	--	$	--	$	7	$	7
Asset impairments and restructuring charges, net
Performance Polymers divested product lines	$	--	$	--	$	--	$	--	$	--
Continuing product lines		--		--		--		46		46
Total asset impairments and restructuring charges, net	$	--	$	--	$	--	$	46	$	46
Other operating (income) charges
Performance Polymers divested product lines	$	--	$	--	$	--	$	(75)	$	(75)
Continuing product lines		--		--		--		--		--
Total other operating (income) charges	$	--	$	--	$	--	$	(75)	$	(75)

⁽¹⁾ Includes allocated costs consistent with the Company’s historical practices, some of which may remain and could be reallocated to the remainder of the segment and other segments.

EASTMAN CHEMICAL COMPANY - EMN	April 26 2007
	5:00 PM EDT
	Page 8

TABLE 6 - OPERATING EARNINGS, NET EARNINGS, AND EARNINGS PER SHARE RECONCILIATION

EARNINGS PER DILUTED SHARE EXCLUDING CERTAIN ITEMS

		First Quarter2007
(Dollars in millions)		Operating Earnings		Earnings Before Tax		Net Earnings		Net earnings per diluted share
As reported	$	135	$	120	$	77	$	0.91
Certain Items:
Accelerated depreciation included in cost of goods sold		14		14		9		0.10
Asset impairments and restructuring charges		21		21		16		0.18
Excluding certain items	$	170	$	155	$	102	$	1.19

		First Quarter2006
(Dollars in millions)		Operating Earnings		Earnings Before Tax		Net Earnings		Net earnings per diluted share
As reported	$	184	$	165	$	105	$	1.27
Certain Items:
Asset impairments and restructuring charges		7		7		7		0.09
Excluding certain items	$	191	$	172	$	112	$	1.36

EASTMAN CHEMICAL COMPANY - EMN	April 26, 2007
	5:00 PM EDT
	Page 9

TABLE 7 - STATEMENTS OF CASH FLOWS

		First Quarter
(Dollars in millions)		2007		2006
Cash flows from operating activities
Net earnings	$	77	$	105
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization		84		74
Asset impairments		22		6
Provision (benefit) for deferred income taxes		(15)		22
Changes in operating assets and liabilities:
(Increase) decrease in receivables		(29)		(55)
(Increase) decrease in inventories		15		(9)
Increase (decrease) in trade payables		(80)		(36)
Increase (decrease) in liabilities for employee benefits and incentive pay		(165)		(82)
Other items, net		25		12
Net cash provided by (used in) operating activities		(66)		37
Cash flows from investing activities
Additions to properties and equipment		(86)		(78)
Proceeds from sale of assets and investments		(2)		7
Additions to capitalized software		(3)		(4)
Other items, net		--		(1)
Net cash provided by (used in) investing activities		(91)		(76)
Cash flows from financing activities
Net increase in commercial paper, credit facility and other borrowings		73		35
Dividends paid to stockholders		(38)		(36)
Treasury stock purchases		(33)		--
Proceeds from stock option exercises and other items		49		1
Net cash provided by (used in) financing activities		51		--
Effect of exchange rate changes on cash and cash equivalents		--		--
Net change in cash and cash equivalents		(106)		(39)
Cash and cash equivalents at beginning of period		939		524
Cash and cash equivalents at end of period	$	833	$	485

EASTMAN CHEMICAL COMPANY - EMN	April 26, 2007
	5:00 PM EDT
	Page 10

TABLE 8 - SELECTED BALANCE SHEET ITEMS

		March 31,		March 31,
(Dollars in millions)		2007		2006
Current Assets	$	2,382	$	1,929
Net Properties		3,034		3,176
Other Assets		700		677
Total Assets	$	6,116	$	5,782
Payables and Other Current Liabilities	$	993	$	993
Short-term Borrowings		--		4
Long-term Borrowings		1,595		1,587
Other Liabilities		1,423		1,481
Stockholders’ Equity		2,105		1,717
Total Liabilities and Stockholders’ Equity	$	6,116	$	5,782